Suppr超能文献

全氟烷基酸和甲状腺激素与肾功能各阶段相关。

Perfluoroalkyl acids and thyroid hormones across stages of kidney function.

机构信息

Dacula, GA, USA.

West Virginia University School of Public Health, Morgantown, WV, USA.

出版信息

Sci Total Environ. 2019 Dec 15;696:133994. doi: 10.1016/j.scitotenv.2019.133994. Epub 2019 Aug 19.

Abstract

Data for US adults aged ≥20 years for 2007-2012 (N = 7020) were used to study concentrations of thyroid stimulating hormone (TSH), free (FT3) and total triiodothyronine (TT3), free (FT4) total thyroxine (TT4), and thyroglobulin (TGN) across stages of glomerular function (GF). Data for 2007-2008 and 2011-2012 (N = 2549) were used to study associations between thyroid hormone biomarkers and five serum perfluoroalkyl acids (PFAAs). We report how thyroid hormone biomarkers vary in human serum across stages of GF. Stages considered were: GF-1 (normal, eGFR >90 mL/min/1.73 m), GF-2 (60 ≤ eGFR≤90 mL/min/1.73 m), GF-3A (45 ≤eGFR<60 mL/min/1.73 m), and GF-3B/4 (15 ≤ eGFR<45 mL/min/1.73 m). Regression models stratified by GF stages were fitted to evaluate associations between the concentrations of selected PFAAs and thyroid hormones and to evaluate the variability in concentrations of thyroid hormones across the stages of GF. Adjusted geometric means (AGM) for TSH sharply increased from GF-1 (1.34 μIU/mL) to GF-2 (1.58 μIU/mL) and then remained relatively stable. AGMs of FT3 and TT3 decreased consistently from GF-1 to GF-3B/4; from 3.24 to 2.79 pg/mL for FT3 and from 115.7 to 96.4 ng/dL for TT3. AGMs for FT4 increased from GF-2 onward. TGN increased as glomerular filtration worsened from GF-1 through GF-3B/4. In contrast to strong relationships of thyroid hormone markers to stages of renal function, only scattered, inconsistent findings characterized relationship of PFAAs to thyroid markers across stages of kidney disease. For example, TSH was positively associated with PFOA at GF-2 (β = 0.08522, p < 0.01) but negatively associated at GF-3A (β = - 0.22926, p = 0.04). Thus, associations between kidney disease and thyroid hormone are clear, but the relationships between PFAAs and thyroid hormones vary inconsistently from stage to stage and reveal no trend. For thyroid hormone investigations, we conclude stratification by glomerular function stage is likely not needed.

摘要

使用 2007-2012 年美国≥20 岁成年人的数据(N=7020),研究肾小球滤过功能(GF)各阶段的促甲状腺激素(TSH)、游离(FT3)和总三碘甲状腺原氨酸(TT3)、游离(FT4)总甲状腺素(TT4)和甲状腺球蛋白(TGN)的浓度。使用 2007-2008 年和 2011-2012 年的数据(N=2549),研究甲状腺激素生物标志物与五种血清全氟烷基酸(PFAAs)之间的关联。我们报告了甲状腺激素生物标志物在人类血清中随 GF 阶段变化的情况。考虑的阶段有:GF-1(正常,eGFR>90mL/min/1.73m)、GF-2(60≤eGFR≤90mL/min/1.73m)、GF-3A(45≤eGFR<60mL/min/1.73m)和 GF-3B/4(15≤eGFR<45mL/min/1.73m)。根据 GF 阶段分层的回归模型用于评估选定 PFAAs 和甲状腺激素之间的浓度与 GF 阶段之间的关系,并评估甲状腺激素浓度在 GF 阶段的变化。TSH 的调整后的几何平均值(AGM)从 GF-1(1.34μIU/mL)急剧增加到 GF-2(1.58μIU/mL),然后保持相对稳定。FT3 和 TT3 的 AGM 从 GF-1 到 GF-3B/4 持续下降;FT3 从 3.24 降至 2.79pg/mL,TT3 从 115.7 降至 96.4ng/dL。FT4 的 AGM 从 GF-2 开始增加。随着肾小球滤过功能恶化,从 GF-1 到 GF-3B/4,TGN 增加。与甲状腺激素标志物与肾功能阶段的强烈关系相反,只有一些不连续、不一致的发现描述了 PFAAs 与疾病各阶段甲状腺标志物之间的关系。例如,TSH 在 GF-2(β=0.08522,p<0.01)与 PFOA 呈正相关,但在 GF-3A(β=-0.22926,p=0.04)呈负相关。因此,肾脏疾病与甲状腺激素之间的关联是明确的,但 PFAAs 与甲状腺激素之间的关系在不同阶段不一致,没有趋势。对于甲状腺激素研究,我们得出结论,肾小球功能阶段分层可能不是必需的。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验